Displaying 921 - 940 of 1552
FTC Staff Opinion: University of Michigans Proposed Rx Program Exempt From Robinson-Patman Act
FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments; FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa; FTC Approves Final Settlement Order Regarding Roaring Fork Valley
Roaring Fork Valley Physicians I.P.A., Inc.
Roaring Fork Valley Physicians, IPA, Inc., a Colorado physicians’ group, settled Commission charges of price-fixing by agreeing to halt its use of allegedly anticompetitive negotiating tactics against health insurers. The Commission charged Roaring Fork Valley Physicians I.P.A., Inc., which represents about 80 percent of the doctors in Garfield County, Colorado, with violating the FTC Act by orchestrating agreements among its members to set higher prices for medical services and to refuse to deal with insurers that did not meet its demands for higher rates.
Higgins, M. Catherine, In the Matter of
The Commission settled charges that the executive director of a Colorado physicians’ association actively tried to evade the terms of a 2008 FTC order by telling insurers that because she was not named individually in the order, she could simply negotiate on behalf of competing physicians on the “outside” and “not with my [association] hat, but as an individual.” The Commission complaint and consent order settling the FTC’s charges name the executive director individually, and will prevent her from orchestrating or implementing price-fixing agreements among the group’s competing physicians.
FTC Approves Final Settlement Orders Regarding Boulder Valley IPA and M. Catherine Higgins; Commission Submits Comments on Measuring the Performance of Electric Regional Transmission Organizations and on FERCs Method of Assessing Partial Acquisitions
Boulder Valley Individual Practice Association
The Commission challenged the conduct of Boulder Valley Individual Practice Association for refusing to deal, or threatening to refuse to deal with insurance providers that failed to increase fees paid to group doctors, and also prevented members from contracting with payers, except through Boulder Valley. During the period between 2001 and 2006 Boulder Valley IPA threatened to terminate contracts with payers unless the payers agreed to pay increased fees-for-service set by Boulder Valley, effectively engaging in illegal price fixing, and harming Boulder country area consumers by charging higher prices for the various physician’s services offered. The settlement prohibits Boulder Valley from entering into agreements between or among physicians: 1) to negotiate on behalf of any physician with any payer; 2) to refuse to deal, or threaten to refuse to deal, with any payer; 3) to designate the terms, conditions, or requirements upon which any physician deals, or is willing to deal, with any payer, including, but not limited to price terms; 4) not to deal individually with any payer, or not to deal with any payer through any arrangement other than one involving Boulder Valley.
Commission Approves Carilion Clinic's Application to Sell Center for Surgical Excellence to Fairlawn Surgery Center, LLC
Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc.
FTC Approves Final Settlement Order Regarding Danaher Corporation and MDS, Inc.
Danaher Corporation and MDS, Inc., In the Matter of
The Commission challenged Danaher’s proposed acquisition of MDS Analytical Technologies, requiring that MDS divest its assets related to its laser microdissection business. The proposed settlement is designed to preserve competition in the North American market for laser microdissection devices – a key tool for scientific research.
Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements
Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal
FTC Warns Marketers of Children's Omega-3 Fatty Acid Supplements That Claims About Brain and Vision Benefits May Be Deceptive
FTC Settles Charges That Colorado Physicians Group Director Attempted to Evade Terms of 2008 Price-Fixing Order
Colorado Physicians Group Agrees to Stop Alleged Price-Fixing Tactics
Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Enforcement Report to
FTC Approves Final Consent Order in Case of Pfizer Inc. and Wyeth
FTC Order Preserves Competition in Market for Important Scientific Research Device, While Allowing Danaher to Proceed with Purchase of MDS Analytical Technologies
Commission Seeks Public Comments on Carilion Clinics Application to Divest Center for Surgical Excellence to Fairlawn Surgery Center, LLC; FTC Approves The Dow Chemical Companys Petition to Divest its Acrylic Acid and Latex Polymers Businesses to Arkema
Displaying 921 - 940 of 1552